DK3334412T3 - Farmaceutisk sammensætning, som omfatter elektrohydrodynamisk opnåede fibre, hvilken sammensætning har forøget opholdstid på påføringsstedet - Google Patents
Farmaceutisk sammensætning, som omfatter elektrohydrodynamisk opnåede fibre, hvilken sammensætning har forøget opholdstid på påføringsstedet Download PDFInfo
- Publication number
- DK3334412T3 DK3334412T3 DK16797943.4T DK16797943T DK3334412T3 DK 3334412 T3 DK3334412 T3 DK 3334412T3 DK 16797943 T DK16797943 T DK 16797943T DK 3334412 T3 DK3334412 T3 DK 3334412T3
- Authority
- DK
- Denmark
- Prior art keywords
- electrohydrodynamic
- residence
- fibers
- acquired
- increased
- Prior art date
Links
- 239000000835 fiber Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nonwoven Fabrics (AREA)
- Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201570745 | 2015-11-19 | ||
| PCT/EP2016/078151 WO2017085264A1 (en) | 2015-11-19 | 2016-11-18 | A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3334412T3 true DK3334412T3 (da) | 2022-01-17 |
Family
ID=58718438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16797943.4T DK3334412T3 (da) | 2015-11-19 | 2016-11-18 | Farmaceutisk sammensætning, som omfatter elektrohydrodynamisk opnåede fibre, hvilken sammensætning har forøget opholdstid på påføringsstedet |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US20180221295A1 (https=) |
| EP (1) | EP3334412B1 (https=) |
| JP (2) | JP6606279B2 (https=) |
| KR (3) | KR102435996B1 (https=) |
| CN (1) | CN108135833B (https=) |
| AU (2) | AU2016358266B2 (https=) |
| BR (1) | BR112018001978A2 (https=) |
| CA (1) | CA2993377C (https=) |
| DK (1) | DK3334412T3 (https=) |
| ES (1) | ES2900741T3 (https=) |
| IL (1) | IL258093B (https=) |
| MX (1) | MX391778B (https=) |
| MY (1) | MY167777A (https=) |
| NZ (1) | NZ740615A (https=) |
| RU (2) | RU2019129082A (https=) |
| SG (1) | SG10201913222XA (https=) |
| WO (1) | WO2017085264A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2019125715A (ru) | 2017-01-23 | 2021-02-24 | Афикс Терапьютикс А/С | Способ изготовления двухслойного продукта на основе электроспряденных волокон |
| BR112019014732A2 (pt) | 2017-01-23 | 2020-03-10 | Afyx Therapeutics A/S | Método para a preparação de fibras eletrofiadas com um alto teor de uma substância bioadesiva |
| WO2021050532A1 (en) * | 2019-09-09 | 2021-03-18 | Afyx Therapeutics A/S | Compositions for treating fungal infections |
| CA3157209A1 (en) | 2019-10-08 | 2021-04-15 | Afyx Therapeutics A/S | Compositions for the delivery of proteins |
| EP4121017A4 (en) * | 2020-03-17 | 2024-07-03 | Blaesi, Aron H. | EXPANDABLE, MULTI-EXCIPIENT STRUCTURED DOSAGE FORM FOR EXTENDED ACTIVE INGREDIENT RELEASE |
| CA3203975A1 (en) | 2020-12-03 | 2022-06-09 | Battelle Memorial Institute | Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery |
| CA3216359A1 (en) | 2021-04-07 | 2022-10-13 | Battelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| EP4108231A1 (en) * | 2021-06-25 | 2022-12-28 | Johann-Wolfgang-Goethe-Universität Frankfurt am Main | In-situ dissolving electrospun polymer fibers for ocular drug delivery |
| PL4124336T3 (pl) * | 2021-07-30 | 2024-02-26 | Cannamedical Pharma Gmbh | Plaster przezśluzówkowy obejmujący kannabinoid i/lub opioid |
| AU2022395509A1 (en) | 2021-11-23 | 2024-06-13 | Afyx Development A/S | Mucosal patches and methods of use thereof |
| WO2024160792A1 (en) * | 2023-01-30 | 2024-08-08 | Cannamedical Pharma Gmbh | Improved transmucosal patch comprising a cannabinoid and/or an opioid |
| CN121843694A (zh) | 2023-09-06 | 2026-04-10 | 阿费克斯发展有限公司 | 用于治疗及预防口腔癌的组合物与方法 |
| AU2024353375A1 (en) | 2023-09-29 | 2026-04-09 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025122954A1 (en) | 2023-12-08 | 2025-06-12 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
| KR20250176151A (ko) * | 2024-06-11 | 2025-12-18 | 주식회사 아이메디텍 | 중재시술용 지혈 의료용 나노섬유 제조방법 및 이에 의한 의료용 나노섬유 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61280423A (ja) | 1985-06-05 | 1986-12-11 | Kiyuukiyuu Yakuhin Kogyo Kk | 口腔内粘膜貼付剤 |
| US6753454B1 (en) * | 1999-10-08 | 2004-06-22 | The University Of Akron | Electrospun fibers and an apparatus therefor |
| JP2003521493A (ja) * | 2000-01-28 | 2003-07-15 | スミスクライン・ビーチャム・コーポレイション | 電気紡糸された医薬組成物 |
| US7309498B2 (en) * | 2001-10-10 | 2007-12-18 | Belenkaya Bronislava G | Biodegradable absorbents and methods of preparation |
| US20030017208A1 (en) * | 2002-07-19 | 2003-01-23 | Francis Ignatious | Electrospun pharmaceutical compositions |
| TW200410714A (en) * | 2002-08-07 | 2004-07-01 | Smithkline Beecham Corp | Electrospun amorphous pharmaceutical compositions |
| CA2495181A1 (en) * | 2002-08-13 | 2004-02-19 | Medtronic, Inc. | Active agent delivery system including a hydrophilic polymer, medical device, and method |
| US9233080B2 (en) * | 2008-03-27 | 2016-01-12 | Agigma, Inc. | Compositions and methods for the delivery of agents |
| WO2013165604A1 (en) * | 2012-05-02 | 2013-11-07 | Massachusetts Institute Of Technology | Electroprocessing of active pharmaceutical ingredients |
| CN102670483B (zh) * | 2012-05-09 | 2014-04-02 | 上海交通大学 | 一种用于高血脂症治疗的静电纺丝纤维膜制剂及其制备方法 |
| US20150290354A1 (en) * | 2012-10-22 | 2015-10-15 | North Carolina State University | Nonwoven fiber materials |
| EP2810645B1 (en) * | 2013-06-06 | 2017-05-24 | A. Sezai Sarac | New Drug Delivery System |
| CA2950821C (en) | 2014-06-10 | 2024-02-06 | Dermtreat Aps | Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa |
-
2016
- 2016-11-18 DK DK16797943.4T patent/DK3334412T3/da active
- 2016-11-18 SG SG10201913222XA patent/SG10201913222XA/en unknown
- 2016-11-18 CN CN201680046647.5A patent/CN108135833B/zh active Active
- 2016-11-18 JP JP2018516015A patent/JP6606279B2/ja active Active
- 2016-11-18 KR KR1020197004754A patent/KR102435996B1/ko active Active
- 2016-11-18 AU AU2016358266A patent/AU2016358266B2/en not_active Ceased
- 2016-11-18 CA CA2993377A patent/CA2993377C/en active Active
- 2016-11-18 ES ES16797943T patent/ES2900741T3/es active Active
- 2016-11-18 MY MYPI2018700176A patent/MY167777A/en unknown
- 2016-11-18 KR KR1020197016484A patent/KR20190067280A/ko not_active Withdrawn
- 2016-11-18 RU RU2019129082A patent/RU2019129082A/ru unknown
- 2016-11-18 WO PCT/EP2016/078151 patent/WO2017085264A1/en not_active Ceased
- 2016-11-18 RU RU2018109496A patent/RU2701513C2/ru active
- 2016-11-18 MX MX2018005206A patent/MX391778B/es unknown
- 2016-11-18 NZ NZ740615A patent/NZ740615A/en not_active IP Right Cessation
- 2016-11-18 KR KR1020187008505A patent/KR102001163B1/ko not_active Expired - Fee Related
- 2016-11-18 EP EP16797943.4A patent/EP3334412B1/en active Active
- 2016-11-18 BR BR112018001978A patent/BR112018001978A2/pt not_active Application Discontinuation
-
2018
- 2018-01-29 US US15/882,637 patent/US20180221295A1/en not_active Abandoned
- 2018-03-13 IL IL258093A patent/IL258093B/en unknown
- 2018-08-21 AU AU2018220020A patent/AU2018220020C1/en not_active Ceased
-
2019
- 2019-04-24 US US16/393,597 patent/US20190254985A1/en not_active Abandoned
- 2019-10-16 JP JP2019189500A patent/JP6929916B2/ja active Active
-
2023
- 2023-05-17 US US18/198,582 patent/US20230285313A1/en not_active Abandoned
-
2024
- 2024-01-05 US US18/406,022 patent/US20240139117A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3334412T3 (da) | Farmaceutisk sammensætning, som omfatter elektrohydrodynamisk opnåede fibre, hvilken sammensætning har forøget opholdstid på påføringsstedet | |
| EP4219808C0 (en) | CELLULOSE FIBERS | |
| EP3392593A4 (en) | STEAM CHAMBER | |
| ES2821790T8 (es) | Moduladores de la vía de estrés integrada | |
| DK3297605T3 (da) | Topiske, farmaceutiske sammesætninger | |
| EP3348581A4 (en) | Modified cellulose fibers | |
| DK3163339T3 (da) | Polariseringsbevarende multikernefiber | |
| EP3290970A4 (en) | MORE CORE FIBER | |
| EP3527596A4 (en) | polyisocyanate | |
| EP3411157A4 (en) | MIST-RESISTANT COATINGS | |
| FI20155406A7 (fi) | Moolimassasäädelty selluloosa | |
| LT3359499T (lt) | Mineralinis pluoštas | |
| CL2019001712A1 (es) | Un monofilamento de fibra. | |
| EP3272917C0 (en) | ANTIMICROBIAL FIBER | |
| IL272375A (en) | Medicinal cannabis | |
| EP3443928C0 (en) | SURGICAL SYSTEM | |
| EP3448446A4 (en) | MECHANICAL INTERLOCKED DEMINERALIZED BONE FIBERS | |
| MA41169A (fr) | Composés antibactériens à large spectre d'activité | |
| BR112016029232A2 (pt) | estruturas que compreendem fibras poliméricas | |
| EP3246047C0 (en) | COMBINATION MEDICATION | |
| EP3306365A4 (en) | MULTILADER FIBER | |
| EP3548655C0 (en) | SPLIT-RESISTANT FIBER | |
| EP3356614C0 (en) | FIBER-REINFORCED POLYMER STRUCTURES | |
| EP3400980A4 (en) | SAFETY SYRINGE | |
| ES1239889Y (es) | Fibra de viscosa modificada |